-
effectivehealthcare.ahrq.gov/products/glaucoma-treatment/research-protocol
November 16, 2010 - A detailed description of Food and Drug Administration (FDA) approval status, indications, and warnings
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prehospital-airway-management-protocol.pdf
December 20, 2019 - Evidence-based Practice Center Systematic Review Protocol: Prehospital Airway Management
Evidence-based Practice Center Systematic Review Protocol
Project Title: Prehospital Airway Management: A Systematic Review
I. Background and Objectives for the Systematic Review
Background
Airway management is one of the…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-informed-care-appendixes.pdf
December 01, 2023 - Evaluation of a trauma-informed and
gender-responsive intervention for women
in drug treatment. … RE-AIM evaluation
framework to test integration of a
Mindfulness Based Parenting intervention
into a drug … Drug and alcohol review. 2015;34(3):242-
51. doi: 10.1111/dar.12230. PMID:
25735200. x
130. … The Portal Project: A Layered Approach to Integrating Trauma into
Alcohol and Other Drug Treatment for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/integrating-evidence_methods.pdf
February 01, 2015 - Integrating Bodies of Evidence: Existing Systematic Reviews and Primary Studies
Methods Guide
for Comparative Effectiveness Reviews
Integrating Bodies of Evidence: Existing Systematic
Reviews and Primary Studies
This report is based on research conducted by the Agency for Healthcare Research and Quality
(AH…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_disposition-comments.pdf
December 11, 2012 - review article note that the meta-analysis
was limited by the "inclusion of studies with
heterogenous drug … review article note that the meta-analysis was
limited by the "inclusion of studies with
heterogenous drug
-
effectivehealthcare.ahrq.gov/health-topics/statins
May 17, 2013 - Update of Comparative Effectiveness of Lipid-Modifying Agents
Research Protocol
Archived
May 17, 2013
Comparative Effectiveness of Lipid-Modifying Agents
Systematic Review
Archived
September 1, 2009
Combination Therapy Versus Intensification of Statin Monotherapy: An Update…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
December 16, 2014 - Food and Drug Administration (FDA). … Food and Drug Administration
(FDA); 2012 Jul 25. 30 p.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_executive.pdf
April 01, 2014 - Food and
Drug Administration (FDA) has approved several
OMBP regimens that are available over the counter
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-224-depression-children-comments.pdf
April 10, 2020 - sentence towards
the bottom of the page:
“…we did not, however, find the same results for SSRIs as a drug … “Studies that defined serious adverse
events generally use the Food and Drug
Administration’s definition
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-224-depression-children-comments.pdf
April 10, 2020 - sentence towards
the bottom of the page:
“…we did not, however, find the same results for SSRIs as a drug … “Studies that defined serious adverse
events generally use the Food and Drug
Administration’s definition
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/procalcitonin_executive.pdf
October 01, 2012 - Immediate
consequences may include decrease in allergic reactions,
drug toxicities, and frequency of … antibiotics,
the incidence of C. difficile, and active surveillance for
colonization of patients with drug-resistant
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-adolescents_executive.pdf
August 01, 2012 - evidence and sharing
information with families routinely take this perspective,
as does the Food and Drug … Administration in mandating
that all adverse events be listed for a drug, rather than just
those for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
January 01, 2012 - interventions (simultaneous targeting of blood
pressure, diabetes, cholesterol, and/or reducing
nephrotoxic drug … CKD: report of a scientific workshop sponsored
by the National Kidney Foundation and the US Food and Drug
-
effectivehealthcare.ahrq.gov/health-topics/inhalants
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-treatment-future_research.pdf
February 01, 2012 - Product makers: This group represents drug and device manufacturers
These categories are not necessarily … discussed that such interventions have been found to be effective in other domains
such as weight control, drug … Represents a health care drug, intervention, device, technology, or health care
system/setting available
-
effectivehealthcare.ahrq.gov/products/undescended-testicle/research-protocol
September 02, 2011 - Current Page Topic Timeline May. 10, 2010 Topic Suggestion Sep. 2, 2011 Research Protocol Dec. 11, 2012 Systematic Review Apr. 19, 2013 Disposition of Comments Report Comparative Effectiveness of Treatments for Cryptorchidism
Research Protocol Archived September 2, 2011 Download Main Document PDF 412.8 KB
…
-
effectivehealthcare.ahrq.gov/products/pain-chronic/research-protocol
July 28, 2010 - Current Page Topic Timeline Jul. 26, 2010 Topic Initiated Jul. 28, 2010 Research Protocol Sep. 30, 2011 Technical Brief Jan. 4, 2012 Disposition of Comments Report Technical Brief: Multidisciplinary Pain Programs for Chronic Non-Cancer Pain
Research Protocol Archived July 28, 2010 Download Main Document PDF 698.6 …
-
effectivehealthcare.ahrq.gov/products/worker-health/research-protocol
May 26, 2015 - status, quality of life, stress or distress
KQ 2b: Intermediate outcomes : Tobacco, alcohol or other drug
-
effectivehealthcare.ahrq.gov/products/gout/research-protocol-2014
July 17, 2014 - Some 32 percent of the costs were attributed to gouty arthritis attacks, and drug expenditures accounted
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-antenatal-care.pdf
April 01, 2021 - Does the nomination represent a health care
drug, intervention, device, technology, or health
care